| ²é¿´: 3805 | »Ø¸´: 1 | ||
ÀîÏþӱгæ (³õÈëÎÄ̳)
|
[ÇóÖú]
CDE·¢²¹ÎÊÌâ ÒÑÓÐ1È˲ÎÓë
|
|
ÎÒÃÇÓиö½ø¿ÚÔÁÏÒ©£¬ÓйØÎïÖÊ·ÖÎö·½·¨²ÉÓõÄÊÇEP8.0רÂ۵ķ½·¨£¬Ö»ÊDzúÆ·±ê×¼ÖÐÔÓÖÊEÎªÌØ¶¨ÔÓÖÊ£¬ÏÞ¶ÈΪ0.15%£¬¶øÅ·ÖÞÒ©µäÖÐÔÓÖÊEΪ·ÇÌØ¶¨ÔÓÖÊÏÞ¶ÈΪ0.10%¡£ÎÒÃÇÕâ¸ö²úÆ·ÒѾ»ñµÃÁËCEPÖ¤Ê飬֤ÊéÖÐÃ÷È·ÁгöÁËÔÓÖÊEµÄÏÞ¶È£¬µ«ÊÇCDEÖÐÐÄ·¢²¹Ìá³öÁËÈçÏÂÎÊÌ⣺ ÐÞ¶©ºóµÄÖÊÁ¿±ê×¼ÓйØÎïÖʲÎÕÕBP2015ͬƷÖÖÏîϵÄÉ«Æ×Ìõ¼þ£¬Å·ÖÞÒ©µä½«ÔÓÖÊE×÷Ϊ·ÇÌØ¶¨ÔÓÖÊ¿ØÖÆ£¬ÏÞ¶ÈΪ0.10%£¬±¾Æ·½«ÔÓÖÊEµÄÏ޶ȶ¨Îª0.15%£¬ÓÐËù·Å¿í¡£½öÌṩÁËÔÓÖÊEµÄ»¯Ñ§Ãû¡¢»¯Ñ§½á¹¹µÈÐÅÏ¢£¬Î´ÌṩÔÓÖÊEµÄ¶¨ÐÔµÈÑо¿ÐÅÏ¢£¬Î´·ÖÎöÔÓÖÊEµÄÒýÈë;¾¶£¬ÒÔ¼°·Å¿íÏ޶ȵÄÒÀ¾Ý¡£½¨ÒéÔÚÎÄÏ׺Í/»òÊÔÑéÊý¾ÝµÄ»ù´¡ÉÏ¶ÔÆäÏ޶ȵĺÏÀíÐÔ½øÐзÖÎö¡£ ¹úÍâ³§¼ÒµÄÒâ¼ûÊÇÔÓÖÊEÏ޶ȵÄÖÆ¶¨×ñÑEPgeneral monograph Substances for pharmaceutical use (2034)ºÍgeneral EP section 5.10. Control of impurities in substances for pharmaceutical use¡£Ä¿Ç°Õâ¸öÀíÓÉÉв»Äܵõ½ÉóÆÀÔ±µÄÈϿɣ¬»¹ÍûÓи߼ûµÄ³æÓѸøÓèÒâ¼û¡£ |
» ²ÂÄãϲ»¶
²ÄÁÏ¿ÆÑ§Ó빤³Ì320Çóµ÷¼Á£¬080500
ÒѾÓÐ9È˻ظ´
0703»¯Ñ§µ÷¼Á 348·Ö
ÒѾÓÐ10È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
Ò»Ö¾Ô¸211£¬0703»¯Ñ§305·ÖÇóµ÷¼Á
ÒѾÓÐ15È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
²ÄÁϹ¤³Ìµ÷¼Á
ÒѾÓÐ5È˻ظ´
287Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
362Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
273Çóµ÷¼Á
ÒѾÓÐ42È˻ظ´
kwskxy
Ìú³æ (ÕýʽдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ½ð±Ò: 177.6
- É¢½ð: 30
- ºì»¨: 2
- Ìû×Ó: 329
- ÔÚÏß: 34.5Сʱ
- ³æºÅ: 1495605
- ×¢²á: 2011-11-16
- רҵ: É«Æ×·ÖÎö

2Â¥2023-04-03 14:23:00














»Ø¸´´ËÂ¥